Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-148,900
Closed -$2.19M 8410
2025
Q3
$2.19M Buy
148,900
+19,100
+15% +$195K ﹤0.01% 2225
2025
Q2
$1.27M Buy
129,800
+28,600
+28% +$237K ﹤0.01% 2545
2025
Q1
$736K Sell
101,200
-44,700
-31% -$391K ﹤0.01% 2738
2024
Q4
$1.14M Buy
145,900
+102,300
+235% +$842K ﹤0.01% 2453
2024
Q3
$323K Sell
43,600
-53,300
-55% -$448K ﹤0.01% 3201
2024
Q2
$776K Buy
96,900
+1,900
+2% +$17K ﹤0.01% 2198
2024
Q1
$1.11M Sell
95,000
-22,400
-19% -$248K ﹤0.01% 2000
2023
Q4
$1.31M Buy
117,400
+28,100
+31% +$258K ﹤0.01% 2212
2023
Q3
$1.38M Sell
89,300
-33,700
-27% -$566K ﹤0.01% 1964
2023
Q2
$2.33M Buy
123,000
+85,100
+225% +$1.49M 0.01% 1563
2023
Q1
$577K Buy
+37,900
New +$494K ﹤0.01% 2636

Other funds holding ETNB

Group One Trading's ETNB Position: Q3 2025 in Review

Group One Trading sold out of 89bio (ETNB) in Q3 2025, closing a stake of 17,177 shares — an estimated $175K sold.

Group One Trading first reported a position in ETNB in Q3 2022 and held it in 12 quarters. The position peaked at $1.36M in Q3 2023. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Group One Trading reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 17,177 89bio shares in Q3 2025, an estimated $175K.
  • Group One Trading first reported a position in 89bio in Q3 2022 and held it in 12 quarters.
  • Group One Trading's 89bio position peaked at $1.36M in Q3 2023.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.